Forian Analyst Ratings
BenzingaApr 4 10:01 ET
Analysts Offer Insights on Healthcare Companies: Forian (FORA), Achieve Life Sciences (ACHV) and P3 Health Partners (PIII)
TipRanksApr 1 09:00 ET
Lake Street Sticks to Its Buy Rating for Forian (FORA)
TipRanksMar 25 08:45 ET
Roth MKM Initiates Coverage On Forian With Buy Rating, Announces Price Target of $5
BenzingaDec 20, 2023 06:29 ET
Forian Analyst Ratings
BenzingaDec 20, 2023 06:28 ET
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Mirati Therapeutics (MRTX) and Forian (FORA)
TipRanksDec 20, 2023 04:40 ET
Lake Street Sticks to Its Buy Rating for Forian (FORA)
TipRanksNov 6, 2023 08:55 ET
Forian (FORA) Gets a Buy From Lake Street
TipRanksOct 4, 2023 08:46 ET
Forian Analyst Ratings
BenzingaAug 11, 2023 12:11 ET
Lake Street Reaffirms Their Buy Rating on Forian (FORA)
TipRanksAug 11, 2023 09:16 ET
National Bank Revises VerticalScope's Price Target, Rating; Resets Forecast Amid Ad Pressure, E-Commerce Challenges
MT NewswiresApr 26, 2023 15:45 ET
Lake Street Sticks to Their Buy Rating for Forian (FORA)
TipRanksMar 28, 2023 09:06 ET
National Bank Cuts Price Target on VerticalScope Holdings Following Q4 Results
MT NewswiresMar 8, 2023 13:22 ET
National Bank Cuts Top-Line Estimate on VerticalScope Holdings, Cuts Price Target; Down 12.6%
MT NewswiresJan 30, 2023 11:56 ET
Forian Analyst Ratings
Benzinga Analyst RatingsNov 10, 2022 08:37 ET
RBC Capital Maintains Outperform on Forian, Lowers Price Target to $17
Benzinga Real-time NewsNov 10, 2022 08:37 ET
National Bank Cuts Price Target on VerticalScope Amid Macro/Recessionary Concerns
MT NewswiresSep 20, 2022 11:20 ET
No Data
No Data